PharmaShots | Incisive News in 3 Shots

Subscribe Now

TYSABRI

Biogen Requests a Preliminary Injunction in BPCIA Case Against Sandoz Proposed Biosimilar of Tysabri (natalizumab)

Biogen Requests a Preliminary Injunction in BPCIA Case Against Sandoz Proposed Biosimilar of Tysabri (natalizumab)

October 27, 2022

PharmaShots Interview: Biogen’s Monica Mann Shares Insights on the New Real-World Data on Tysabri & Vumerity for the Treatment of Multiple Sclerosis

PharmaShots Interview: Biogen’s Monica Mann Shares Insights on the New Real-World Data on Tysabri & Vumerity for the Treatment of...

May 17, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us